DrugPatentWatch Database Preview
United Therap Company Profile
What is the competitive landscape for UNITED THERAP, and when can generic versions of UNITED THERAP drugs launch?
UNITED THERAP has four approved drugs.
There are twenty-one US patents protecting UNITED THERAP drugs.
There are ninety-eight patent family members on UNITED THERAP drugs in nine countries.
Summary for United Therap
| International Patents: | 98 |
| US Patents: | 21 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 4 |
| Patent Litigation for United Therap: | See patent lawsuits for United Therap |
| PTAB Cases with United Therap as patent owner: | See PTAB cases with United Therap as patent owner |
Drugs and US Patents for United Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-005 | Oct 7, 2016 | RX | Yes | No | 9,604,901 | Start Trial | Y | Start Trial | |||
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-002 | May 21, 2002 | AP | RX | Yes | Yes | 9,604,901 | Start Trial | Y | Start Trial | ||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-004 | Dec 20, 2013 | RX | Yes | No | 8,410,169 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for United Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-002 | May 21, 2002 | 5,153,222 | Start Trial |
| United Therap | TYVASO | treprostinil | SOLUTION;INHALATION | 022387-001 | Jul 30, 2009 | 6,521,212 | Start Trial |
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-001 | May 21, 2002 | 5,153,222 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for UNITED THERAP drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 10 mg/mL, 20 mL vial | ➤ Subscribe | 2011-12-02 |
| ➤ Subscribe | Inhalation Solution | 0.6 mg/mL, 2.9 mL ampules | ➤ Subscribe | 2015-04-13 |
| ➤ Subscribe | Extended-release Tablets | 0.25 mg and 1 mg | ➤ Subscribe | 2016-05-19 |
| ➤ Subscribe | Injection | 1 mg/mL, 2.5 mg/mL, and 5 mg/mL, 20 mL vial | ➤ Subscribe | 2012-12-07 |
| ➤ Subscribe | Extended-release Tablets | 2.5 mg | ➤ Subscribe | 2015-12-24 |
International Patents for United Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 101161889 | Start Trial |
| Austria | 532520 | Start Trial |
| Spain | 2377387 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
